Question
CAP – Defining the Diagnosis |
Q01 | Definition and diagnosis of community-acquired pneumonia (CAP) |
Q02 | Investigating the CAP patient – what is required? |
Q03 | Risk factors for a poor prognosis |
The Pathogens Responsible for CAP and their Antimicrobial Susceptibility |
Pharmacokinetic Features of Fluoroquinolones |
International Society Guidelines for the Management of CAP |
Levofloxacin – Preeminent Respiratory Fluoroquinolone |